Do Not Give Up Hope: When You Understand
The Cause Of Cancer You Can Stop Its Growth!
889. Jee SH, et al. “Fasting serum glucose level and cancer risk in Korean men and women.” Journal of American Medical Association, (JAMA). Volume 293, Number 2, Pages 194-202. January 12, 2005. http://jama.ama-assn.org/cgi/content/abstract/293/2/194?etoc
890. Stattin P, et al. “Prospective Study of Hyperglycemia and Cancer Risk.” Diabetes Care. Volume 30, page 561-567. 2007 http://care.diabetesjournals.org/cgi/content/abstract/30/3/561?ijkey=ef5c7a5dd4b2ae780d2e1c36b26818d5b9dc44be&keytype2=tf_ipsecsha
891. Augustin LSA, et al.. “Glycemic Index, Glycemic Load, and Risk of Gastric Cancer.” Annals of Oncology, Volume 15, Number 4, Pages 581-584. 2004. http://annonc.oxfordjournals.org/cgi/content/abstract/15/4/581
892. Wang F, Herrington M, Larsson J and Permert J. “The relationship between diabetes and pancreatic cancer.” Molecular Cancer, Volume 2, Number 4. 2003. http://www.molecular-cancer.com/content/2/1/4
893. Michaud DS, et al. “Dietary Sugar, Glycemic Load, and Pancreatic Cancer Risk in a Prospective Study.” Journal of National Cancer Institute, Volume 94, Number 17, Pages 1293–1300. 2002. http://jnci.oxfordjournals.org/cgi/reprint/94/17/1293
894. Kaaks R, Lukanova A and Kurzer MS. “Obesity, Endogenous Hormones, and Endometrial Cancer Risk.” Cancer Epidemiology Biomarkers & Prevention Volume 11, Number 12, Pages 1531-1543, December 2002. http://cebp.aacrjournals.org/cgi/content/full/11/12/1531
895. Augustin LSA, et al. “Glycemic Index and Glycemic Load in Endometrial Cancer.” International Journal of Cancer Volume 105, Number 3, Pages 404-7. June 20, 2003. http://www3.interscience.wiley.com/cgi-bin/abstract/104081808/ABSTRACT?CRETRY=1&SRETRY=0
896. Augustin LSA, et al. “Dietary Glycemic Index, Glycemic Load and Ovarian Cancer Risk: a case–control study in Italy.” Annals of Oncology, Volume 14, Number 1, Pages 78-84, 2003. http://annonc.oxfordjournals.org/cgi/content/full/14/1/78
897. Silvera SAN, et al. “Dietary carbohydrates and breast cancer risk: a prospective study of the roles of overall glycemic index and glycemic load.” International Journal of Cancer, Volume 114, Number 4, Pages 653-8. Apr 20, 2005. http://www.cababstractsplus.org/google/abstract.asp?AcNo=20053067002
898. Higginbotham S, et al. “Dietary Glycemic Load and Breast Cancer Risk in the Women’s Health Study.” Cancer Epidemiology Biomarkers & Prevention, Volume 13, Number 1, Pages 65-70, January 2004. http://cebp.aacrjournals.org/cgi/content/abstract/13/1/65
899. Michaud DS, et al. “Dietary Glycemic Load, Carbohydrate, Sugar, and Colorectal Cancer Risk in Men and Women.” the Cancer Epidemiology Biomarkers & Prevention Volume 14, Number 1, Pages 138-147, January 2005. http://cebp.aacrjournals.org/cgi/reprint/14/1/138
900. Higginbotham S, et al. “Dietary Glycemic Load and Risk of Colorectal Cancer in the Women’s Health Study.” Journal of National Cancer Institute, 2004; 96:229 –33. http://jnci.oxfordjournals.org/cgi/reprint/96/3/229
901. Nelson WG, et al. “THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER.” the Journal of Urology Volume 172, Pages S6–S12, November 2004. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=15535435&dopt=AbstractPlus
902. Augustin LSA, et al. “GLYCEMIC INDEX, GLYCEMIC LOAD AND RISK OF PROSTATE CANCER.” Internaional Journal of Cancer Volume 112, Pages 446–450. 2004. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=15382070&cmd=showdetailview&indexed=google
903. De Stefani E, et al. “Dietary sugar and lung cancer: a case-control study in Uruguay.” Nutrition and Cancer, Volume 31, number 2, Pages 132-7. 1998. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=pubmed&dopt=AbstractPlus&list_uids=9770725&query_hl=2&itool=pubmed_DocSum.
904. Sargeant LA, et al. “Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer–Norfolk (EPIC-Norfolk) study: a population-based study.” Diabetes Care, Volume 23, Number 6, Pages 726-32. June 2000. http://care.diabetesjournals.org/cgi/reprint/23/6/726.pdf
905. Krone CA and Ely JTA. “Controlling Hyperglycemia as an Adjunct to Cancer Therapy.” Integrated Cancer Therapies, Volume 4, Number 1, Pages 25-31. 2005. http://ict.sagepub.com/cgi/content/abstract/4/1/25
906. Ely JTA. “Glycemic Modulation of Tumor Tolerance.” Journal of Orthomolecular Medicine, Volume 11, Number 1, Pages 23-34. 1996. http://faculty.washington.edu/ely/JOM1.html
907. Lin J, et al. “A Prospective Study of Hemoglobin A1c Concentrations and Risk of Breast Cancer in Women.” Cancer Research Volume 66, Number 5, Pages 2869-2875. March 1, 2006. http://cancerres.aacrjournals.org/cgi/reprint/66/5/2869
908. Donaldson MS. Nutrition and cancer: A review of the evidence for an anti-cancer diet. The Nutrition Journal. Volume 3, Number 19. 2004. http://www.nutritionj.com/content/3/1/19
909. van Heijst JWJ, Niessen HWM, Hoekman K and Schalkwijk CG. “Advanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidine.” Annals of the New York Academy of Science. Volume1043, Number 1, Pages 725-33. June 2005. http://www.annalsonline.org/cgi/content/abstract/1043/1/725
910. Borugian MJ, et al. “Carbohydrates and Colorectal Cancer Risk among Chinese in North America.” Cancer Epidemiology, Biomarkers & Prevention.. Volume 11, Number 12, Pages 187–193, February 2002 http://cebp.aacrjournals.org/cgi/reprint/11/2/187
911. Byers T, et al. “American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer with Healthy Food Choices and Physical Activity.” CA Cancer Journal for Clinicians Volume 52, Number 2, Pages 92-119. 2002. http://caonline.amcancersoc.org/cgi/content/full/52/2/92
912. Wiseman H and Halliwell B. “Review: Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer.” Biochemistry Journal. Volume 313, Pages 17–29. 1996. http://www.biochemj.org/bj/313/0017/3130017.pdf
913. Mariani SM. Conference “Report: Breast Cancer: Prevention, Prediction, and Treatment.” (Highlights From the 2003 Annual Meeting of the American Association for Cancer Research; April 5-9, 2003. Toronto, Ontario, Canada. Medscape General Medicine Volume 5, Number 2. 2003. http://www.medscape.com/viewarticle/452119
914. Schottenfeld D. “Alcohol as a co-factor in the etiology of cancer.” Cancer.Volume 43, Issue S5, Pages 1962-1966. http://www3.interscience.wiley.com/cgi-bin/abstract/112680608/ABSTRACT?CRETRY=1&SRETRY=0
915. Schots R, et al. “Post-transplant complications: An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation.” Bone Marrow Transplantation. Volume 30, Pages 441–446. 2002. http://www.nature.com/bmt/index.html
916. Min C-K, et al. “Post-Transplant Events: Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse.” Bone Marrow Transplantation. Volume 37, Number 5, Pages 493–498. 2006. Published online 23 January 2006. http://www.nature.com/bmt/journal/v37/n5/abs/1705276a.html
917. Jancin B. “Virus May Trigger Many Cases of Breast Cancer.” INTERNAL MEDICINE NEWS • February 15, 2007. http://www.internalmedicinenews.com/article/PIIS1097869007701518/fulltext
918. Siemes C, et al. “C-Reactive Protein Levels, Variation in the C-Reactive Protein Gene, and Cancer Risk: The Rotterdam Study.” Journal of Clinical Oncology, Volume 24, Number 33, Pages 5216-5222. November 20, 2006. http://jco.ascopubs.org/cgi/content/abstract/24/33/5216
919. Langman MJS, Cheng KK, Gilman EA and Lancashire RJ. “Effect of anti-inflammatory drugs on overall risk of common cancer: case control study in general practice research database.” British Medical Journal. Volume 320, Number 7250, Pages 1642–1646. June 17;, 2000. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27410
920. McLaughlin JK, et al. “Etiology of cancer of the renal pelvis. Etiology of cancer of the renal pelvis.” Journal of the Natlional Cancer Institue. Volume 71, Number 2, Pages 287-91. August 1983. http://www.uta.edu/faculty/sawasthi/Publications/References/Books/Book%201/Document%201.17.pdf
921. Liu L-T, et al.. “Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.” Oncogene. Volume 21, Pages 8347 – 8350. 2002. http://www.nature.com/onc/journal/v21/n54/abs/1206017a.html
922. Whitcomb DC. “Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer.” American Journal of Physiology – Gastrointestine and Liver Physiology Volume 287, Pages G315-G319. 2004. http://ajpgi.physiology.org/cgi/content/full/287/2/G315
923. Lu H, Ouyang W and Huang C. “Inflammation, a Key Event in Cancer Development.” Molecular Cancer Research. Volume 4, Number 4, Pages 221-233. 2006. http://mcr.aacrjournals.org/cgi/reprint/4/4/221
924. Erlinger TP, Platz EA, Rifai N and Helzlsouer KJ. “C-Reactive Protein and the Risk of Incident Colorectal Cancer.” The Journal of American Medical Association. Volume 291 Number 5, Pages 585-590. February 4, 2004. http://jama.ama-assn.org/cgi/reprint/291/5/585
925. Wall RJ, Shyr Y and Smalley W. “Nonsteroidal Anti-Inflammatory Drugs and Lung Cancer Risk: A Population-Based Case Control Study.” Journal of Thoracic Oncology: Volume 2, Number 2, Pages 109-114. February 2007.
926. Khuder SA, Herial NA, Mutgi AB and Federman DJ. “A Metaanalysis. Nonsteroidal Antiinflammatory Drug Use and Lung Cancer.” Chest. Volume 127, Number 3, Pages 748-754. 2005. http://www.chestjournal.org/cgi/content/abstract/127/3/748
927. Lowenfels AB, et al. “Pancreatitis and the Risk of Pancreatic Cancer.” The New England Journal of Medicine. Volume 328, Number 20, Pages 1433-1437. May 20, 1993. http://content.nejm.org/cgi/content/short/328/20/1433
928. Risch HA and Howe GR. “Pelvic inflammatory disease and the risk of epithelial ovarian cancer.” Cancer Epidemiology Biomarkers & Prevention, Volume 4, Issue 5, Pages 447-451. July/August 1995. http://cebp.aacrjournals.org/cgi/reprint/4/5/447
929. Trichopoulos D, et al. “Plasma C-Reactive Protein and Risk of Cancer A Prospective Study from Greece.” Cancer Epidemiology, Biomarkers & Prevention. Volume 15, Number 2, Pages 381–4. 2006. http://cebp.aacrjournals.org/cgi/content/abstract/15/2/381
930. Sin DD, Man SFP, McWilliams A and Lam S. “Progression of Airway Dysplasia and C-Reactive Protein in Smokers at High Risk of Lung Cancer.” American Journal of Respiratory and Critical Care Medicine. Volume 173, Number 5, Pages 535-539. 2006. http://ajrccm.atsjournals.org/cgi/content/full/173/5/535
931. Merletti F, et al. “Role of Tobacco and Alcoholic Beverages in the Etiology of Cancer of the Oral Cavity/Oropharynx in Torino, Italy.” Cancer Research. Volume 49, Number 17, Pages 4919-4924, September 1, 1989. http://cancerres.aacrjournals.org/cgi/reprint/49/17/4919
932. Wang WH, et al. “Non-steroidal Anti-inflammatory Drug Use and the Risk of Gastric Cancer: A Systematic Review and Meta-analysis” Journal of the National Cancer Institute, Volume 95, Number 23, Pages 1784-1791. 2003. http://jnci.oxfordjournals.org/cgi/content/abstract/95/23/1784
933. Reuters. “Risks of aspirin outweigh cancer benefit for most.” 03/16/2007. http://www.reuters.com/article/healthNews/idUSTON71115320070307
934. Halber D. News Office Correspondent. “Studies link cancer, inflammatory disease.” news office, Massachusetts Institute of Technology. March 29, 2006. http://web.mit.edu/newsoffice/2006/cancer-links.html
935. Gross L. “The role of viruses in the etiology of cancer and leukemia in animals and in humans.” Proceeding of the National Academy of Science of the United States of America. Volume 94, Number 9, Pages 4237-4238. April 1997. http://www.pnas.org/cgi/reprint/94/9/4237
936. Higginbotham S, et al. “ Brief Communication: Dietary Glycemic Load and Risk of Colorectal Cancer in the Women’s Health Study.” Journal of the National Cancer Institute, Volume 96, Number 3, Pages 229-233, February 4, 2004. http://jnci.oxfordjournals.org/cgi/reprint/jnci%3b96/3/229
937. Ohyama C, et al. “Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.” Glycobiology Advance Access originally published online on March 24, 2004. Volume 14, Number 8, Pages 671-679. http://glycob.oxfordjournals.org/cgi/reprint/14/8/671
938. Donaldson MS. “Nutrition and cancer: A review of the evidence for an anti-cancer diet.” Nutrition Journal. Volume 3, Number 19. 2004. http://www.nutritionj.com/content/3/1/19
939. “Chronic inflammatory conditions that predisposes susceptible cells to neoplastic transformation.” http://i.cmpnet.com/cancernetwork/journals/oncology/images/o0202dt1.gif
940. Moyad MA, Sakr WA, Hirano D and Miller GJ. “Complementary Medicine for Prostate Cancer: Effects of Soy and Fat Consumption.” Reviews in Urol.ogy. Volume 3, Supplement 2, Pages S20–S30. 2001. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1476079&rendertype=abstract
941. Holmes MD, et al. “Physical Activity and Survival After Breast Cancer Diagnosis.” Journal of American Medical Association. Volume 293, Number 20, Pages 2479-2486. 2005. http://jama.ama-assn.org/cgi/content/full/293/20/2479?ijkey=dbfe13e7c07869a9c100a81c9919bf6f0de8aa96
942. McTiernan A, et al. “Adiposity and Sex Hormones in Postmenopausal Breast Cancer Survivors.” Journal of Clinical Oncology, Volume 21, Issue 10, Pages 1961-1966. May 2003. http://jco.ascopubs.org/cgi/content/full/21/10/1961
943. Larsson SC, Bergkvist L and Wolk A. “Consumption of sugar and sugar-sweetened foods and the risk of pancreatic cancer in a prospective study.” American Journal of Clinical Nutrition. Volume 84, Number 5, Pages 1171-1176, November 2006. http://www.ajcn.org/cgi/content/abstract/84/5/1171
944. Anderson KE, et al. “Diabetes and Endometrial Cancer in the Iowa Women’s Health Study.” Cancer Epidemiology Biomarkers & Prevention. Volume 10, Number 6, Pages 611-616, June 2001. http://cebp.aacrjournals.org/cgi/reprint/10/6/611
945. Rodriguez C, et al. “Diabetes and Risk of Prostate Cancer in a Prospective Cohort of US Men.” American Journal of Epidemiology.. Volume 161, Number 2. Pages 147-152. 2005. http://aje.oxfordjournals.org/cgi/content/abstract/161/2/147
946. De Rekeneire N, et al. “Diabetes, Hyperglycemia, and Inflammation in Older Individuals: The Health, Aging and Body Composition study.” Diabetes Care. Volume 29, Number 8, Pages 1902-8. August 2006. http://care.diabetesjournals.org/cgi/content/abstract/29/8/1902
947. Kaklamani VG, et al. “Dietary Fat and Carbohydrates Are Independently Associated With Circulating Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor–Binding Protein 3 Concentrations in Healthy Adults.” ournal of Clinical Oncology, Volume 17, Issue 10, Pages 3291-3298. October 1999. http://jco.ascopubs.org/cgi/content/abstract/17/10/3291
948. Michaud DS, et al. “Dietary Patterns and Pancreatic Cancer Risk in Men and Women.” Journal of the National Cancer Institute, Volume 97, Number 7. Pages 518-524. April 2005. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=15812077&cmd=showdetailview&indexed=google
949. Chen R, et al. The initiation of colon cancer in a chronic inflammatory setting.” Carcinogenesis. Volume 26, Number 9, Pages.1513–1519, 2005. http://carcin.oxfordjournals.org/cgi/reprint/26/9/1513
950. Coussens LM and Werb Z. “ Inflammation and cancer.” Nature. Volume 420, Number 6917, Pages 860-7. December 19-26, 2002. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=12490959&cmd=showdetailview&indexed=google
951. Schottenfeld D and Beebe-Dimmer J. “Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia.” A Cancer Journal for Clinicians. Volume 56, Number 2, Pages 69–83. 2006. http://caonline.amcancersoc.org/cgi/reprint/56/2/69
952. Michels KB, et al. “Type 2 Diabetes and Subsequent Incidence of Breast Cancer in the Nurses’ Health Study.” Diabetes Care. Volume 26, Number 6, Pages 1752–1758, 2003. http://care.diabetesjournals.org/cgi/content/full/26/6/1752
953. Bostick RM, et al. “Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States).” Cancer Causes Control. Volume 5, Number 1, Pages 38-52. January 1994. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=8123778&cmd=showdetailview&indexed=google
954. Tavani A. et al. “Consumption of sweet foods and breast cancer risk in Italy.“ Annals of Oncology. Volume 17, Pages 341–345, 2006. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=16249211&cmd=showdetailview&indexed=google
955. Ghadirian P, Baillargeon J, Simard J and Perret C. “Food habits and pancreatic cancer: a case-control study of the Francophone community in Montreal, Canada.” Cancer Epidemiology Biomarkers & Prevention. Volume 4, Issue 8, Pages 895-899. 1995. http://cebp.aacrjournals.org/cgi/content/abstract/4/8/895
956. Leij-Halfwerk S, et al. “Hepatic sugar phosphate levels reflect gluconeogenesis in lung cancer: simultaneous turnover measurements and 31P magnetic resonance spectroscopy in vivo.” Clinical Science. Volume 98, Pages 167–174. 2000. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=10657272&cmd=showdetailview&indexed=google
957. Shankar A. et al. “Association Between Circulating White Blood Cell Count and Cancer Mortality.” ArchivesS of Internal MedicineE. Volume 166, Number 2, Pages 188- 194. January 23, 2006. http://archinte.ama-assn.org/cgi/reprint/166/2/188.pdf
958. Jhu K, et al. “History of Diabetes Mellitus and Risk of Prostate Cancer in Physicians.” American Journal of Epidemiology. Volume 159, Number 10, Pages 978-982. 2004. http://aje.oxfordjournals.org/cgi/reprint/159/10/978
959. McCarl M, et al. “ncidence of Colorectal Cancer in Relation to Glycemic Index and Load in a Cohort of Women.” Cancer Epidemiology Biomarkers & Prevention. Volume 15, Number 5, Pages 892-896, May 2006. http://cebp.aacrjournals.org/cgi/reprint/15/5/892
960. Potischman N, et al.. “Increased risk of early-stage breast cancer related to consumption of sweet foods among women less than age 45 in the United States.” Cancer Causes Control. Volume 3, Number 10, Pages 937-46. December 2002. http://www.springerlink.com/content/up3x1wl047318475
961. Flak RT, et al. “Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women.” Breast cancer research and treatment. Volume 98, Number 2, Pages 157-65. July 2006. http://www.springerlink.com/content/d6w720l88w6g321x/
962. Folsom AR, Demissie Z and Harnack L. “Glycemic Index, Glycemic Load, and Incidence of Endometrial Cancer: The Iowa Women’s Health Study.” Nutrition and Cancer. 2003, Volume 46, Number 2, Pages 119-124. http://www.cababstractsplus.org/google/abstract.asp?AcNo=20043184182
963. Vera JC, et al. “Human HL-60 Myeloid Leukemia Cells Transport Dehydroascorbic Acid Via the Glucose Transporters and Accumulate Reduced Ascorbic Acid.” Blood. Volume 84, Number 5, Pages 1628-1634. September l, 1994. http://bloodjournal.hematologylibrary.org/cgi/content/abstract/84/5/1628
964. Keding SJ and Danishefsky SJ. “Prospects for total synthesis: A vision for a totally synthetic vaccine targeting epithelial tumors.” Proceedings of the National Academy of Science of the United States of America. Volume 101, Number 33, Pages 11937-11942. August 17, 2004. http://www.pnas.org/cgi/reprint/101/33/11937
965. Ragupathi G, et al. “On the power of chemical synthesis: Immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.” Proceedings of the National Academy of Science of the United States of America. Volume 99, Number 21, Pages 13699-13704. October 15, 2002. http://www.pnas.org/cgi/reprint/99/21/13699
966. Slovin SF and Scher HI. “Peptide and carbohydrate vaccines in relapsed prostate cancer: immunogenicity of synthetic vaccines in man–clinical trials at Memorial Sloan-Kettering Cancer Center.” Seminars in Oncology. Volume 26, Number 4, Pages 448-54. August 1999. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=10482187&cmd=showdetailview&indexed=google
967. Margolis KL, et al. “Prospective Study of Leukocyte Count as a Predictor of Incident Breast, Colorectal, Endometrial, and Lung Cancer and Mortality in Postmenopausal Women.” Archives of Internal Medicine. Volume 167, Number 17, Pages 837-1844. 2007. http://archinte.ama-assn.org/cgi/content/short/167/17/1837
968. Chatenoud,L, et al. “Refined-cereal intake and risk of selected cancers in Italy.” American Journal of Clinical Nutrition. Volume 70, Number 6, Pages 1107–10. 1999. http://www.ajcn.org/cgi/content/abstract/70/6/1107
969. Valko M, et al. “Role of oxygen radicals in DNA damage and cancer” Molecular and Cellular Biochemistry. Volume 266, Number 1-2, Pages 37-56. November 2004. http://www.springerlink.com/content/l0142851222k3h75
970. Jayaprakash V, et al. “Chemoprevention of Head and Neck Cancer With Aspirin: A Case-Control Study.” Archives of Otolaryngologyl-Head Neck Surgery. Volume 132, Number 11, Pages 1231-1236. 2006. http://archotol.ama-assn.org/cgi/content/abstract/132/11/1231
971. Among hospitalized h AT, Ogino S and Fuchs CS. “Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2.” New England Journal Of Medicine, Volume 356, Number 21, Pages 2131-2142. May 24, 2007. http://content.nejm.org/cgi/content/full/356/21/2131
972. Persaud,SJ, Burns CJ, Belin VD and Jones PM. “Glucose-Induced Regulation of COX-2 Expression in Human Islets of Langerhans.” Diabetes. Volume 53, Supplement. 1, Pages S190–S192, 2004. http://diabetes.diabetesjournals.org/cgi/reprint/53/suppl_1/S190.pdf
973. Terry MB, et al. “Association of Frequency and Duration of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk.” Journal of American Medical Association. Volume 291 Number 20, Pages 2433-2440. May 26, 2004. http://jama.ama-assn.org/cgi/content/abstract/291/20/2433?ijkey=a01296aba35cd15c235f7ed8d10f3ee91ba792d6&keytype2=tf_ipsecsha
974. Delfino RJ, et al.. “Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype.” Carcinogenesis. Volume 21 Number 4. Pages 607-615. 2000. http://carcin.oxfordjournals.org/cgi/reprint/21/4/607
975. Zhou W, et al. “The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer.” Nutrition & Metabolism. Volume 4, Number 5. 2007. http://www.nutritionandmetabolism.com/content/pdf/1743-7075-4-5.pdf
976. Ingredients.com/Europe. “Low-carb diet keeps prostate cancer at bay?” NUTRA. October 28, 2003. http://www.nutraingredients.com/news/printNewsBis.asp?id=38908
977. Freeland SJ, et al. “Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis.” The Prostate. Volume 68, Issue 1, Pages 11-19. January 1, 2008. http://www.ncbi.nlm.nih.gov/pubmed/17999389?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
978. Wu AH, et al. “Diabetes and risk of breast cancer in Asian-American women.” Carcinogenesis. Volume 28, Number 7, Pages 1561-1566. 2007. http://carcin.oxfordjournals.org/cgi/content/abstract/28/7/1561
979. Pösch G and Seitz HK “REVIEW:. ALCOHOL AND CANCER.” Alcohol & Alcoholism. Volume 39, Number 3, Pages. 155–165, 2004. http://alcalc.oxfordjournals.org/cgi/reprint/39/3/155
980. Cowey S and Hardy RW. “Review. The Metabolic Syndrome: A High-Risk State for Cancer?” American Journal of Pathology. Volume 169, Number 5, Pages 1505–1522. 2006. http://ajp.amjpathol.org/cgi/reprint/169/5/1505
981. Shacter E and Weitzmen SA. “Chronic Inflammation and Cancer.” Oncology. Volume 16, Number 2, Pages 217-26, and 229. February 2002. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=11866137&cmd=showdetailview&indexed=google
982. National Cancer Institute. “Executive Summary of Inflammation and Cancer Think Tank.” Division of Cancer Biology. http://dcb.nci.nih.gov/thinktank/Executive_Summary_of_Inflammation_and_Cancer_Think_Tank.cfm
983. Gulam W and Ahsan H. “Reactive oxygen species: role in the development of cancer and various chronic conditions.” Journal of Carcinogenesis Volume 5, Number 14. 2006. http://www.carcinogenesis.com/content/pdf/1477-3163-5-14.pdf
984. Kasum CM, Blair CK, Folsom AR and Ross JA. “Non-steroidal Anti-inflammatory Drug Use and Risk of Adult Leukemia.” Cancer Epidemiology, Biomarkers & Prevention. Volume 12, Number 6, 534–537, June 2003. http://cebp.aacrjournals.org/cgi/content/full/12/6/534
985. Zhou XM, et al. “Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak.” Carcinogenesis. Volume 22, Number 9, Pages 1393-1397, September 2001. http://carcin.oxfordjournals.org/cgi/reprint/22/9/1393
986. Surh Y-J, Kundu JK, Na H-K and Lee J-S. “Redox-Sensitive Transcription Factors as Prime Targets for Chemoprevention with Anti-Inflammatory and Antioxidative Phytochemicals.” Journal of Nutrition. Volume 135, Number 12, Pages 2993S-3001S, December 2005. http://jn.nutrition.org/cgi/reprint/135/12/2993S
987. Kreeger K. Inflammation’s infamy: The body’s first line of defense just may be the ‘root of all evil.” The Scientist. Volume 17, Issue 14, Page 28. July 14, 2003. http://www.the-scientist.com/article/display/13943
988. Liu E, et al. “Aspirin Use and Risk of Biliary Tract Cancer: A Population-Based Study in Shanghai, China.” Cancer Epidemiology, Biomarkers & Prevention. Volume 14, Number 5. Pages 1312-1318. May 2005. http://cebp.aacrjournals.org/cgi/content/abstract/14/5/1315
989. National Cancer Institute. ” Aspirin May Reduce Risk of Colon Polyps.” Clinical Trial Results. Posted: 04/09/2002 Reviewed: 10/31/2005 http://www.cancer.gov/clinicaltrials/results/aspirin0402
990. Rahme E. et al. “Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.” BioMed Central Cancer. Volume 5, Number 159. December 2005. http://www.biomedcentral.com/1471-2407/5/159
991. Chan AT, et al. “Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer.” Journal of American Medical Association. Volume 294, Number 8, Pages 914-923. August 24/31, 2005. http://jama.ama-assn.org/cgi/content/full/294/8/914
992. Anderson LA, et al. “Nonsteroidal Anti-inflammatory Drugs and the Esophageal Inflammation-Metaplasia-Adenocarcinoma Sequence.” Cancer Research. Volume 66, Number 9, Pages 4975-4982, May 1, 2006. http://cancerres.aacrjournals.org/cgi/content/full/66/9/4975
993. García Rodríguez LA. and Huerta-Alvarez C. “Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs.” Epidermiology. Volume 12, Number 1, Pages 88-93. January 2001. http://www.epidem.com/pt/re/epidemiology/fulltext.00001648-200101000-00015.htm;jsessionid=H0bpGpH67TW2pg1YnKQtMw8qzV2pHnZGnQFXWqJ1rmckQDQq9pFs!1390229169!181195629!8091!-1?&fullimage=true
994. Barsheshet A, et al. “Admission Blood Glucose Level and Mortality Among Hospitalized Nondiabetic Patients With Heart Failure.” Archives of Internal Medicine. Volume166, Number 15. Pages 1613-1619. August 14/28, 2006. http://archinte.ama-assn.org/cgi/reprint/166/15/1613
995. Moysich KB, et al. “Regular aspirin use and lung cancer risk.” BioMed Central Cancer. Volume 2, Number 31.2002. http://www.biomedcentral.com/1471-2407/2/31
996. Wall RJ, Shyr Y and Smalley W. “Nonsteroidal Anti-Inflammatory Drugs and Lung Cancer Risk: A Population-Based Case Control Study.” Journal of Thoracic Oncology . Volume 2, Number 2, February 2007. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=17410024&cmd=showdetailview&indexed=google
997. National Cancer Institute. “Aspirin Use Is Not Associated with Pancreatic Cancer Mortality, Study Reports.” NCI Cancer Bulletin. Volume 1, Number 16. Page 4#b. April 20, 2004. http://www.cancer.gov/ncicancerbulletin/NCI_Cancer_Bulletin_042004/page4#b
998. National Cancer Institute. “Aspirin Protective Against Prostate Cancer, Study Suggests.” NCI Cancer Bulletin. Volume 1, Number 13, Page 6#a. March 30, 2004. http://www.cancer.gov/ncicancerbulletin/NCI_Cancer_Bulletin_033004/page6#a
999. National Cancer Institute. “Lower Breast Cancer Risk With Aspirin Linked to Hormone-Receptor Status.” NCI Cancer Bulletin. Volume 1, Number 21. May 25, 2004. http://www.cancer.gov/NCICancerBulletin/NCI_Cancer_Bulletin_052504
1000. Cotterchio M et al. “Nonsteroidal Anti-inflammatory Drug Use and Breast Cancer Risk.” Cancer Epidemiology Biomarkers & Prevention. Volume 10, Number 11, Pages 1213-1217, November 2001. http://cebp.aacrjournals.org/cgi/reprint/10/11/1213
1001. National Cancer Institute. “Nonsteroidal Anti-Inflammatory Drugs and Cancer Prevention.” Surveilance Epidemiology and End Results. http://seer.cancer.gov/studies/epidemiology/study17.html
1002. Baron JA, et al. “A Randomized Trial of Aspirin to Prevent Colorectal Adenomas.” New England Journal of Medicine. Volume 348, Number 10, Pages 891-899. March 6, 2003. http://content.nejm.org/cgi/content/full/348/10/891
1003. Griffeth LK. “Use of PET/CT scanning in cancer patients: technical and practical considerations.” Baylor University Med Center Proceedings. Volume 18, Number 4, Pages 321–330. October 2005. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16252023
1004. Biddinger SB and Ludwig DS. “The insulin-like growth factor axis: a potential link between glycemic index and cancer American Journal of Clinical Nutrition, Voolume 82, Number 2, Pages 277– 8. 2005. http://www.ajcn.org/cgi/reprint/82/2/277.pdf
1005. Maggio M, et al. “Circulating Inflammatory Cytokine Expression in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy.” Journal of Andrology. Volume 27, Number 6, Pages 725-728. November/December 2006. http://www.andrologyjournal.org/cgi/content/abstract/27/6/725
1006. Dennis LK, et al. “Epidemiologic association between prostatitis and prostate cancer.” Urology. Volume 60, Number 1, Pages 78-83. July 2002.
1007. Platz EA, et al. “Epidemiology of Inflammation and Prostate Cancer.” The Journal of Urology. Volume 171, Issue 2 (supplement), Pages S36-S40, Feb. 2004. http://www.jurology.com/article/PIIS0022534705625165/abstract
1008. Nelson WG, et al. “The Role of Inflammation in The Pathogenesis of Prostate Cancer.” The Journal of Urology. Volume 172, Pages S6–S12, November 2004.
1009. Nelson, WG. “Free Radicals: The Pros and Cons of Antioxidants. Prostate Cancer Prevention.” Journal of Nutrition. Volume 134, Number 11, Pages 3211S-3212S, November 2004. http://jn.nutrition.org/cgi/reprint/134/11/3211S
1010. MacLenman GT, et al. “The Influence of Chronic Inflammation in Prostatic Carcinogenesis: A 5-Year Followup Study.” Journal of Urology. Volume 176, Number 3, Pages 1012-1016. September 2006.
1011. Shahangian S, et al. “Pancreatic oncofetal antigen and carbohydrate antigen 19-9 in sera of patients with cancer of the pancreas.” Clinical Chemistry, Volume 35, Number 3, Pages 405-408. 1989. http://www.clinchem.org/cgi/reprint/35/3/405
1012. Bartling B, et al. “Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma.” Carcinogenesis. Volume.26, Number 2, Pages 293–301, 2005. http://carcin.oxfordjournals.org/cgi/reprint/26/2/293
1013. Kuniyasu H, et al. “Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.” ONCOLOGY REPORTS. Volume 10, Number 2, Pages 445-448, 2003. http://histology1.med.uoc.gror/2003/Volume10/number2/445.pdf
1014. JEROEN WJ, et al. “Advanced Glycation End Products in Human Cancer Tissues: Detection of N-(Carboxymethyl)lysine and Argpyrimidine.” Annals of New York Academy of. Science. Volume 1043, Number 1, Pages 725–733. 2005. http://www.annalsnyas.org/cgi/content/abstract/1043/1/725
1015. Maskarinec G and Meng L. “An investigation of soy intake and mammographic characteristics in Hawaii.” Breast Cancer Research. Volume 3, Number 2, Pages 134–141. 2001. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=13924
1016. Grandics P. “Cancer: a single disease with a multitude of manifestions?” Journal of Carcinogenesis. Volume 2, Number 9. November 18, 2003. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=305362
1017. Slovin SF, et al. “Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.” Proceedings of the National Academy of Science of the United States of America. Volume 96, Number 10, Pages 5710–5715. May 11, 1999. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=21925
1018. Bynard AR and Lopez CB. “Conjugated linoleic acid (CLA) versus saturated fats/cholesterol: their proportion in fatty and lean meats may affect the risk of developing colon cancer.” Lipids in Health and Diseases. Volume 2, Number 6. 2003. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=201014
1019. Bosmann HB and Hall TC. “Enzyme Activity in Invasive Tumors of Human Breast and Colon.” Proceedings of the National Academy of Science of the United States of America. Volume 71, Number 5, Pages 1833–1837. May 1974. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=388336
1020. Prentice RL. “Future possibilities in the prevention of breast cancer: Fat and fiber and breast cancer research.” Breast Cancer Research. Volume 2, Number 4, Pages 268–276. 2000. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=138787
1021. Balkau B, et al. “Hyperinsulinemia Predicts Fatal Liver Cancer but Is Inversely Associated With Fatal Cancer at Some Other Sites. The Paris Prospective Study.” Diabetes Care. Volume 24, Number 5, Pages 843–849. 2001. http://care.diabetesjournals.org/cgi/content/full/24/5/843
1022. Koike T, et al. “Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates.” Proceedings of the National Academy of Science of the United States of America. Volume 101, Number 21, Pages 8132–8137. May 25, 2004. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=419569
1023. Gilewski T, et al. “Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial.” Proceedings of the National Academy of Science of the United States of America. Volume 98, Number 6, Pages 3270–3275. March 13, 2001. http://www.pubmedcentral.gov/articlerender.fcgi?artid=30643
1024. Meinbach DS and Lokeshwar BL. “Insulin-like growth factors and their binding proteins in prostate cancer: Cause or consequence?” Urologic Oncology. Volume 24, Pages 294–306. 2006.
1025. Keding SJ and Danishefsky SJ. “Prospects for total synthesis: A vision for a totally synthetic vaccine targeting epithelial tumors.” Proceedings of the National Academy of Science of the United States of America. Volume 101, Number 33, Pages 11937–11942. August 17, 2004. http://www.pubmedcentral.gov/articlerender.fcgi?artid=514412
1026. Chari ST, et al. “Probability of Pancreatic Cancer Following Diabetes: A Population-Based Study.” Gastroenterology. Volume 129, Number 2, Pages 504-511. August 2005.
1027. ACR RSNA. “Positron Emission Tomography (PET Imaging).” Radiology Info. http://www.radiologyinfo.org/content/petomography.htm
1028. Gapstur SM, et al. “Postload plasma glucose concentration and 27-year prostate cancer mortality (United States).” Cancer Causes and Control. Volume 12, Number 8, Pages 763-72. October 2001. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11562117&dopt=Abstract
1029. Barnard RJ. “Prevention of Cancer Through Lifestyle Changes.” Evidence Based Complementary and Alternative Medicine. Volume 1, Number 3, Pages 233–239. December 2004. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=538507
1030. Tsai HK, et al. “Androgen deprivation therapy for prostate cancer and the risk of cardiac mortality.” American Society of Clinical Oncology 2007 Prostate Cancer Symposium. http://www.asco.org/portal/site/ASCO/menuitem.34d60f5624ba07fd506fe310ee37a01d/?vgnextoid=76f8201eb61a7010VgnVCM100000ed730ad1RCRD&vmview=abst_detail_view&confID=46&abstractID=20299
1031. Harata K, et al. “Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells.” Hepatogastroenterology. Volume 50, Number 53, Pages 1205-7. Sep-Oct 2003. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14571699&dopt=Abstract
1032. Wang P, et al. “The relationship between diabetes and pancreatic cancer.” Molecular Cancer. Volume 2, Page 4. 2003. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=149418
1033. Richardson LC and Pollack LA. “Therapy Insight: Influence of Type II Diabetes on the Development, Treatment and Outcomes of Cancer.” National Clinical Practical Oncology. Volume 2, Number 1, Pages 48-53. 2005. http://www.medscape.com/viewarticle/498299
1034. Nakaji S, et al. “Dietary fiber showed no preventive effect against colon and rectal cancers in Japanese with low fat intake: an analysis from the results of nutrition surveys from 23 Japanese prefectures.” BMC Cancer. Volume 1, page 14. 2001. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=59673
1035. Hill AF, et al. “The significance of glucose, insulin and potassium for immunology and oncology: a new model of immunity.” Journal of Immune Based Therapies and Vaccines (Bio Med Central). Volume 3, Number 5, 2005. http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1201164
1036. The Ohio State University Medical Center. “Hyperglycemia Linked to Hospital Mortality in AML Patients.” Press Release. June 4, 2007. http://medicalcenter.osu.edu/mediaroom/press/article.cfm?ID=3254
1037. Vu KD, et al. “Hyperglycemia and obesity in patients (pts) with acute lymphoblastic leukemia (ALL): Association with prevalence, response, and survival.” Journal of Clinical Oncology. 2007 ASCO Annual Meeting Proceedings Part I. Volume 25, Number 18S, Abstract 7074. June 20, 2007. http://meeting.ascopubs.org/cgi/content/abstract/25/18_suppl/7074
1038. Ali NA, et al. “Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality.” Cancer. Volume 110, Issue 1, Pages 96-102. May 2007. http://www3.interscience.wiley.com/cgi-bin/abstract/114274332/ABSTRACT?CRETRY=1&SRETRY=0
1039. Torizuka, T. “Effect of Hyperglycemia on In Vitro Tumor Uptake of Tritiated FDG, Thymidine, L-Methionine and L-Leucine.” JOURNAL OF NUCLEAR MEDICINE. Volume 38, Number 3, Pages 382-386. March 1997. http://jnm.snmjournals.org/cgi/reprint/38/3/382
1040. Inoue M, et al. “Diabetes Mellitus and the Risk of Cancer. Results From a Large-Scale Population-Based Cohort Study in Japan.” Archives of Internal Medicine. Volume 166:, Pages 871-1877. 2006. http://archinte.ama-assn.org/cgi/reprint/166/17/1871
1041. Ness R and Cottreau C. “Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer.” Journal of the National Cancer Institute. Volume 91, Number 17, Pages 1459-1467. 1999. http://jnci.oxfordjournals.org/cgi/reprint/91/17/1459
1042. Merritt MA, et al. “Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer..” International Journal of Cancer. Volume 122, Number 1, Pages 170-6. January 1, 2008. http://www.ncbi.nlm.nih.gov/pubmed/17721999?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus
1043. Pischon T, et al. “Body Size and Risk of Colon and Rectal Cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC).” Journal of the National Cancer Institute. Volume 98, Number 13, Pages 920-931. 2006.
1044. Kolonel LN, et al. “Dietary Fat and Prostate Cancer: Current Status.” Journal of the National Cancer Institute, Volume 91, Number 5, Pages 414-428. March 3, 1999. http://jnci.oxfordjournals.org/cgi/reprint/jnci%3b91/5/414
1045. Kushi L and Giovannucci E. “Dietary fat and cancer.” American Journal of Medicine. Volume 113, Supplement 9B, Pages 63S-70S. December 30, 2002. http://www.ncbi.nlm.nih.gov/pubmed/12566141
1046. Jarvinen R, et al. “Dietary fat, cholesterol and colorectal cancer in a prospective study.” British Journal of Cancer. Volume 85, Number 3, Pages 357-61. August 3, 2001. http://www.nature.com/bjc/journal/v85/n3/abs/6691906a.html
1047. Stattin P, et al. “High Levels of Circulating Insulin-Like Growth Factor-I Increase Prostate Cancer Risk: A Prospective Study in a Population-Based Nonscreened Cohort.” Journal of Clinical Oncology. Volume 22, Number 15, Pages 3104-3112. August 1, 2004. http://jco.ascopubs.org/cgi/reprint/22/15/3104
1048. Prentice RL, et al. “Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer. The Women’s Health Initiative Randomized Controlled Dietary Modification Trial.” Journal of the American Medical Association. Volume 295, Number 6, Pages 629-642. 2006. http://jama.ama-assn.org/cgi/content/full/295/6/629
1049. Beresford, SAA, et al. “Low-Fat Dietary Pattern and Risk of Colorectal Cancer. The Women’s Health Initiative Randomized Controlled Dietary Modification Trial.” Journal of the American Medical Association. Volume 295, Pages 643-654. 2006. http://jama.ama-assn.org/cgi/reprint/295/6/643
1050. Demark-Wahnefried W, et al. “Pilot Study of Dietary fat Restriction and Flaxseed Supplementation in Men with Prostate Cancer Before Surgery: Exploring The Effects on Hormonal Levels, Prostate-Specific Antigen, and Histopathologic Features.” Journal of Urology. Volume 58, Number 1, Pages 47–52. July 2001. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=search&term=11445478%5Buid%5D
1051. Dennis LK, et al. “Problems with the Assessment of Dietary Fat in Prostate Cancer Studies.” American Journal of Epidemiology. Volume 160, Number 5, Pages 436-444. 2004. http://aje.oxfordjournals.org/cgi/reprint/160/5/436
1052. Franceschi S, et al. “Dietary glycemic load and colorectal cancer risk.” Annals of Oncology. Volume 12, Pages 173-178. 2001. http://annonc.oxfordjournals.org/cgi/reprint/12/2/173
1053. Jayaprakash V, et al. “Chemoprevention of Head and Neck Cancer With Aspirin.” Archives of Otolaryngology-Head & Neck Surgery. Volume 132, Pages 1231-1236. 2006. http://archotol.ama-assn.org/cgi/reprint/132/11/1231
1054. Hong, S, et al. “Detection of viral infections in prostate tumor tissues associated with RNase L variant R462Q.” http://www.toll2006.org/uploads/43cd6422dc300%20abstact%20brazil%20meetingvs32.pdf
1055. Ohyama C, et al,. “Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.” Glycobiology. Volume 14, Number 8, Pages 671-679. March 2004. http://glycob.oxfordjournals.org/cgi/reprint/14/8/671
1056. Phillips AN, et al. “The Leukocyte Count and Risk of Lung Cancer.” Cancer. Volume 69, Issue 3, Pages 680-684. 1992. http://www3.interscience.wiley.com/cgi-bin/abstract/112674965/ABSTRACT?CRETRY=1&SRETRY=0
1057. Dennis LK and Dawson DV. “Meta-Analysis of Measures of Sexual Activity and Prostate Cancer.” Epidemiology. Volume 13, Number 1, Pages 72-9. January 2002. http://www.ncbi.nlm.nih.gov/pubmed/11805589
1058. Rodriguez C, et al. “Body Mass Index, Height, and Prostate Cancer Mortality in Two Large Cohorts of Adult Men in the United States.” Cancer Epidemiology Biomarkers & Prevention. Volume 10, Pages 345-353. April 2001. http://cebp.aacrjournals.org/cgi/reprint/10/4/345
1059. Lasalvia-Prisco E. et al. “Insulin-induced enhancement of antitumoral response to methotrexate in breast cancer patients.” Cancer Chemotherapy and Pharmacology. Volume 53, Number 3, Pages 220-4. March 2004. http://www.ncbi.nlm.nih.gov/pubmed/14655024
1060. American Cancer Society. “Insulin Potentiation Therapy.” Making Treatment Decisions. http://www.cancer.org/docroot/ETO/content/ETO_5_3X_Insulin_Potentiation_Therapy.asp?sitearea=ETO&viewmode=print&
1061. Zhang C, et al. “Abdominal Obesity and the Risk of All-Cause, Cardiovascular, and Cancer Mortality.” Circulation. Volume 117, Issue 13, Pages 1658-1667. April 1, 2008. http://circ.ahajournals.org/cgi/content/abstract/117/13/1658
Do Not Give Up Hope: When You Understand
The Cause Of Cancer You Can Stop Its Growth!
Previous | Study Guide | Next
